212 related articles for article (PubMed ID: 20889194)
21. Increased expression of TACI on NOD B cells results in germinal centre reaction anomalies, enhanced plasma cell differentiation and immunoglobulin production.
Banday VS; Thyagarajan R; Sundström M; Lejon K
Immunology; 2016 Nov; 149(3):297-305. PubMed ID: 27444337
[TBL] [Abstract][Full Text] [Related]
22. Genetics of common variable immunodeficiency: role of transmembrane activator and calcium modulator and cyclophilin ligand interactor.
Sathkumara HD; De Silva NR; Handunnetti S; De Silva AD
Int J Immunogenet; 2015 Aug; 42(4):239-53. PubMed ID: 26096648
[TBL] [Abstract][Full Text] [Related]
23. TACI, isotype switching, CVID and IgAD.
Castigli E; Geha RS
Immunol Res; 2007; 38(1-3):102-11. PubMed ID: 17917015
[TBL] [Abstract][Full Text] [Related]
24. Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency.
Kutukculer N; Gulez N; Karaca NE; Aksu G; Berdeli A
J Clin Immunol; 2012 Dec; 32(6):1165-79. PubMed ID: 22699762
[TBL] [Abstract][Full Text] [Related]
25. Effect of TACI signaling on humoral immunity and autoimmune diseases.
Zhang Y; Li J; Zhang YM; Zhang XM; Tao J
J Immunol Res; 2015; 2015():247426. PubMed ID: 25866827
[TBL] [Abstract][Full Text] [Related]
26. TACI is mutant in common variable immunodeficiency and IgA deficiency.
Castigli E; Wilson SA; Garibyan L; Rachid R; Bonilla F; Schneider L; Geha RS
Nat Genet; 2005 Aug; 37(8):829-34. PubMed ID: 16007086
[TBL] [Abstract][Full Text] [Related]
27. Immunological characteristics and two novel mutations in TACI in a cohort of 28 pediatric patients with common variable immunodeficiency.
Almejún MB; Sajaroff E; Galicchio M; Oleastro M; Bernasconi A; Zelazko M; Danielian S
J Clin Immunol; 2012 Feb; 32(1):89-97. PubMed ID: 22076597
[TBL] [Abstract][Full Text] [Related]
28. Differential induction of plasma cells by isoforms of human TACI.
Garcia-Carmona Y; Cols M; Ting AT; Radigan L; Yuk FJ; Zhang L; Cerutti A; Cunningham-Rundles C
Blood; 2015 Mar; 125(11):1749-58. PubMed ID: 25631768
[TBL] [Abstract][Full Text] [Related]
29. TACI is required for efficient plasma cell differentiation in response to T-independent type 2 antigens.
Mantchev GT; Cortesão CS; Rebrovich M; Cascalho M; Bram RJ
J Immunol; 2007 Aug; 179(4):2282-8. PubMed ID: 17675489
[TBL] [Abstract][Full Text] [Related]
30. TACI deficiency - a complex system out of balance.
Salzer U; Grimbacher B
Curr Opin Immunol; 2021 Aug; 71():81-88. PubMed ID: 34247095
[TBL] [Abstract][Full Text] [Related]
31. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes.
Salzer U; Bacchelli C; Buckridge S; Pan-Hammarström Q; Jennings S; Lougaris V; Bergbreiter A; Hagena T; Birmelin J; Plebani A; Webster AD; Peter HH; Suez D; Chapel H; McLean-Tooke A; Spickett GP; Anover-Sombke S; Ochs HD; Urschel S; Belohradsky BH; Ugrinovic S; Kumararatne DS; Lawrence TC; Holm AM; Franco JL; Schulze I; Schneider P; Gertz EM; Schäffer AA; Hammarström L; Thrasher AJ; Gaspar HB; Grimbacher B
Blood; 2009 Feb; 113(9):1967-76. PubMed ID: 18981294
[TBL] [Abstract][Full Text] [Related]
32. Ligand-independent oligomerization of TACI is controlled by the transmembrane domain and regulates proliferation of activated B cells.
Smulski CR; Zhang L; Burek M; Teixidó Rubio A; Briem JS; Sica MP; Sevdali E; Vigolo M; Willen L; Odermatt P; Istanbullu D; Herr S; Cavallari M; Hess H; Rizzi M; Eibel H; Schneider P
Cell Rep; 2022 Mar; 38(13):110583. PubMed ID: 35354034
[TBL] [Abstract][Full Text] [Related]
33. TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen.
Tsuji S; Stein L; Kamada N; Nuñez G; Bram R; Vallance BA; Sousa AE; Platt JL; Cascalho M
J Clin Invest; 2014 Nov; 124(11):4857-66. PubMed ID: 25271628
[TBL] [Abstract][Full Text] [Related]
34. Molecular basis of common variable immunodeficiency.
Castigli E; Geha RS
J Allergy Clin Immunol; 2006 Apr; 117(4):740-6; quiz 747. PubMed ID: 16630927
[TBL] [Abstract][Full Text] [Related]
35.
Cascalho M; Platt JL
Front Immunol; 2021; 12():634544. PubMed ID: 33679786
[TBL] [Abstract][Full Text] [Related]
36. Impaired B cell receptor signaling is responsible for reduced TACI expression and function in X-linked immunodeficient mice.
Uslu K; Coleman AS; Allman WR; Katsenelson N; Bram RJ; Alugupalli KR; Akkoyunlu M
J Immunol; 2014 Apr; 192(8):3582-95. PubMed ID: 24646744
[TBL] [Abstract][Full Text] [Related]
37. Functional analysis of transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI) mutations associated with common variable immunodeficiency.
Fried AJ; Rauter I; Dillon SR; Jabara HH; Geha RS
J Allergy Clin Immunol; 2011 Jul; 128(1):226-228.e1. PubMed ID: 21419480
[TBL] [Abstract][Full Text] [Related]
38. CVID-associated TACI mutations affect autoreactive B cell selection and activation.
Romberg N; Chamberlain N; Saadoun D; Gentile M; Kinnunen T; Ng YS; Virdee M; Menard L; Cantaert T; Morbach H; Rachid R; Martinez-Pomar N; Matamoros N; Geha R; Grimbacher B; Cerutti A; Cunningham-Rundles C; Meffre E
J Clin Invest; 2013 Oct; 123(10):4283-93. PubMed ID: 24051380
[TBL] [Abstract][Full Text] [Related]
39. TACI mutation with invasive polyclonal CD8+ T-cell lymphoproliferation in a patient with common variable immunodeficiency.
Berglund LJ; Jones GJ; Murali R; Fulcher DA
J Allergy Clin Immunol; 2006 Apr; 117(4):870-7. PubMed ID: 16630947
[TBL] [Abstract][Full Text] [Related]
40. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.
Barbosa RR; Silva SL; Silva SP; Melo AC; Pereira-Santos MC; Barata JT; Hammarström L; Cascalho M; Sousa AE
J Clin Immunol; 2014 Jul; 34(5):573-83. PubMed ID: 24809296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
